Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009 and headquartered in Andover, Massachusetts.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2014 | Series D | $34M | 1 | — | — | Detail |
| Mar 1, 2013 | Series C | $10.73M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
General Catalyst
|
— | Series D |